Cha et al. reported that mutant KRAS expressed in CRC cells selectively promoted exosome secretion of miRNA-100, while wild-type KRAS accelerated exosome export of miRNA-10b, which is consistent with other report performed in the mouse pancreatic cancer model induced by mutant KRAS [140]. This evidence concerns the gene KRAS and pancreatic neoplasm.